Path ID: DB08908_MESH_D011565_1

db08908-mesh-d011565-1

Concepts

Identifier Name Type
DB:DB08908 Dimethyl fumarate Drug
GO:0038061 NIK/NF-kappaB signaling BiologicalProcess
GO:0001816 Cytokine production BiologicalProcess
GO:0006954 Inflammatory response BiologicalProcess
reactome:R-HSA-8932339 ROS sensing by NFE2L2 Pathway
UniProt:P09601 Heme oxygenase 1 Protein
UniProt:Q8TDS4 Hydroxycarboxylic acid receptor 2 Protein
GO:1990266 Neutrophil migration BiologicalProcess
MESH:D011565 Psoriasis Disease

Relationships

NOTE: predicates are annotated in Biolink Model (v1.3.0)

Subject Predicate Object
Dimethyl Fumarate NEGATIVELY REGULATES Nik/Nf-Kappab Signaling
Nik/Nf-Kappab Signaling POSITIVELY REGULATES Cytokine Production
Cytokine Production POSITIVELY CORRELATED WITH Inflammatory Response
Dimethyl Fumarate POSITIVELY REGULATES Ros Sensing By Nfe2L2
Ros Sensing By Nfe2L2 INCREASES ACTIVITY OF Heme Oxygenase 1
Heme Oxygenase 1 NEGATIVELY REGULATES Inflammatory Response
Dimethyl Fumarate INCREASES ACTIVITY OF Hydroxycarboxylic Acid Receptor 2
Hydroxycarboxylic Acid Receptor 2 NEGATIVELY REGULATES Neutrophil Migration
Neutrophil Migration POSITIVELY CORRELATED WITH Inflammatory Response
Inflammatory Response CAUSES Psoriasis

Comment: Fumaric acid is used for the treatment of psoriasis in an ester form as dimethyl fumarate. This graph was made for dimethyl fumarate. Dimethyl fumarate ia a prodrug which is metabolised into the pharmacologically active monomethyl fumarate.

Reference: